Optic nerve head component analysis enters the clinic
Will multifocal ERG be the next OCT?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Over the last decade, assessment of the optic nerve has blossomed not only as a means of evaluating the integrity of the anterior visual pathways but also as an indirect reflection of cortical and subcortical integrity in demyelinating and degenerative neurologic disease.1,2 The bulk of research has involved optical coherence tomography (OCT), which utilizes low coherent light, much like an ultrasound, to measure the thickness of the retinal nerve fiber layer (RNFL), which contains the axons forming the optic nerve, and, more recently, the thickness of the macular ganglion cell layer, which contains the cell bodies of those axons.3,4 Despite the many advantages of OCT, its weakness is that it fails to detect an acute lesion that has not yet altered the structure of the associated retinal components, or any nonstructural optic nerve dysfunction, for that matter. The visual evoked potential (VEP) measures the amplitude and delay of occipital electrical activity while one eye is subject to flashes of light, thus measuring the function of the optic apparatus more directly, but its ability to finely localize injury or to determine a specific etiology is limited.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 545
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007 -
Drugs and Devices
The application of optical coherence tomography in neurologic diseasesRamiro S. Maldonado, Pradeep Mettu, Mays El-Dairi et al.Neurology: Clinical Practice, September 17, 2015 -
Article
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MSMarco Pisa, Simone Guerrieri, Giovanni Di Maggio et al.Neurology, November 15, 2017 -
Article
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaElias S. Sotirchos, Shiv Saidha, Gita Byraiah et al.Neurology, March 20, 2013